Beckman Coulter

Beckman Foundation Announces High School Legacy Program Awardees

Retrieved on: 
Wednesday, July 12, 2023

IRVINE, Calif., July 12, 2023 /PRNewswire-PRWeb/ -- The Arnold and Mabel Beckman Foundation announced today the selection of its 2023 class of Orange County Beckman Legacy Awardees. Six high school students were awarded for their excellent lab work after building a spectrophotometer and conducting an independent research project under the mentorship of their science teachers. This annual Orange County high school program supported by the Foundation honors Dr. Arnold O. Beckman's legacy and his many inventions, including the spectrophotometer, while exemplifying the Foundation's mission to support young scientists.

Key Points: 
  • IRVINE, Calif., July 12, 2023 /PRNewswire-PRWeb/ -- The Arnold and Mabel Beckman Foundation announced today the selection of its 2023 class of Orange County Beckman Legacy Awardees.
  • This annual Orange County high school program supported by the Foundation honors Dr. Arnold O. Beckman's legacy and his many inventions, including the spectrophotometer, while exemplifying the Foundation's mission to support young scientists.
  • High schools from six school districts in Orange County, California were invited to participate in the third year of the program.
  • Since its inception, the program supplied nearly two dozen local high school students with a total of $272,000 in college scholarships.

Lab Automation Market to be Worth $11.60 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Monday, July 10, 2023

Read 200-page market research report, " Lab Automation Market Size, Share & Trends Analysis Report By Process (Continuous Flow, Discrete Processing), By Automation Type (Total Automation Systems, Modular Automation Systems), By End-use, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.

Key Points: 
  • Read 200-page market research report, " Lab Automation Market Size, Share & Trends Analysis Report By Process (Continuous Flow, Discrete Processing), By Automation Type (Total Automation Systems, Modular Automation Systems), By End-use, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • The rising application of lab automation for speeding up laboratory processes is one of the major factors contributing to market expansion.
  • Moreover, the rising integration of lab automation with advanced digitalization and connectivity trends is likely to offer significant growth opportunities for the market in the coming years.
  • Similarly, in April 2023 Molgen acquired Synchron lab automation, a leader in lab automated systems.

Lab Automation Market to be Worth $11.60 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Monday, July 10, 2023

Read 200-page market research report, " Lab Automation Market Size, Share & Trends Analysis Report By Process (Continuous Flow, Discrete Processing), By Automation Type (Total Automation Systems, Modular Automation Systems), By End-use, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.

Key Points: 
  • Read 200-page market research report, " Lab Automation Market Size, Share & Trends Analysis Report By Process (Continuous Flow, Discrete Processing), By Automation Type (Total Automation Systems, Modular Automation Systems), By End-use, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • The rising application of lab automation for speeding up laboratory processes is one of the major factors contributing to market expansion.
  • Moreover, the rising integration of lab automation with advanced digitalization and connectivity trends is likely to offer significant growth opportunities for the market in the coming years.
  • Similarly, in April 2023 Molgen acquired Synchron lab automation, a leader in lab automated systems.

Phantom Neuro Announces Conclusion of PreClinical Demonstration, Team Growth & Preparation for Human Trials

Retrieved on: 
Tuesday, June 27, 2023

AUSTIN, Texas, June 27, 2023 /PRNewswire/ -- Phantom Neuro, the pioneering neurotech startup, today announced the successful demonstration of their technology in a porcine model. The company is developing the world's first minimally invasive muscle-machine interface for lifelike control of robotic prosthetic limbs and exoskeletons.

Key Points: 
  • The company is developing the world's first minimally invasive muscle-machine interface for lifelike control of robotic prosthetic limbs and exoskeletons.
  • - Dr. Glass, CEO of Phantom Neuro
    The startup has also announced the addition of a new Chief Technology Officer, Mike Faltys.
  • Launched in 2022, Phantom Neuro aims to dramatically enhance the lives of amputees and individuals with various limb deficits.
  • Current investors in Phantom Neuro include Time BioVentures, Risk & Return (R²), LionBird Ventures, Draper Associates, and Breakout Ventures, among others.

Rare Element Resources Announces Completion of Funding Agreement for $4.4 Million Wyoming Energy Authority Grant

Retrieved on: 
Thursday, June 8, 2023

Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce the completion of the funding agreement for the previously announced $4.4 million grant from the Wyoming Energy Authority (the “WEA”).

Key Points: 
  • Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce the completion of the funding agreement for the previously announced $4.4 million grant from the Wyoming Energy Authority (the “WEA”).
  • Once approved by the NRC, Wyoming will have primacy for the NRC’s licensing of Wyoming-based rare earth processing facilities.
  • Rare Element Resources Ltd. is a publicly traded, strategic materials company focused on delivering rare earth products for technology, energy, and defense applications by advancing the Bear Lodge Critical Rare Earth Project in northeast Wyoming.
  • The WEA was created in 2020 by the Wyoming State Legislature by merging the Wyoming Infrastructure Authority and the Wyoming Pipeline Authority.

Brain-computer interface to control digital devices using thoughts: The European Patent Office has announced that Australian researchers have been selected as finalists for the European Inventor Award 2023

Retrieved on: 
Tuesday, May 30, 2023

In an effort to improve the quality of life for those affected, Australian researchers Drs.

Key Points: 
  • In an effort to improve the quality of life for those affected, Australian researchers Drs.
  • Thomas Oxley and Nicholas Opie invented a brain-computer interface system that transmits data from the brain wirelessly to control external digital devices hands-free, to enable patients with severe paralysis to communicate using their thoughts.
  • The research duo are finalists for the European Inventor Award in the 'Non-EPO Countries' category in recognition of their promising work.
  • The winners will be announced at a hybrid ceremony on 4 July 2023 in Valencia (Spain).

Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance

Retrieved on: 
Monday, May 15, 2023

ROME, May 15, 2023 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2).  

Key Points: 
  • According to Julie Sawyer Montgomery, President, Beckman Coulter Diagnostics, "The DxI 9000 Access Immunoassay Analyzer sets new expectations for immunoassay testing operational performance and ability to develop and sustain improved assay sensitivity to meet tomorrow's analytical needs.
  • In particular, the team loved the un-paralleled Zero Daily Maintenance especially for a platform that runs 450 tests per hour."
  • Beta users attest to ZeroDaily Maintenance redefining their workday with no daily maintenance requirements, thereby reducing annual maintenance routines by up to 96%.
  • Speakers include Dr. Pamela Christudoss, and Kathleen Orland, Senior Vice President & General Manager, Clinical Chemistry and Immunoassay Business Unit, Beckman Coulter Diagnostics.

Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance

Retrieved on: 
Monday, May 15, 2023

ROME, May 15, 2023 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2).  

Key Points: 
  • According to Julie Sawyer Montgomery, President, Beckman Coulter Diagnostics, "The DxI 9000 Access Immunoassay Analyzer sets new expectations for immunoassay testing operational performance and ability to develop and sustain improved assay sensitivity to meet tomorrow's analytical needs.
  • In particular, the team loved the un-paralleled Zero Daily Maintenance especially for a platform that runs 450 tests per hour."
  • Beta users attest to ZeroDaily Maintenance redefining their workday with no daily maintenance requirements, thereby reducing annual maintenance routines by up to 96%.
  • Speakers include Dr. Pamela Christudoss, and Kathleen Orland, Senior Vice President & General Manager, Clinical Chemistry and Immunoassay Business Unit, Beckman Coulter Diagnostics.

Rare Element Resources to Participate in the Emerging Growth Metals, Minerals and Energy Conference

Retrieved on: 
Wednesday, May 10, 2023

Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce that it will be presenting at the Emerging Growth Metals, Minerals and Energy Conference on May 17, 2023.

Key Points: 
  • Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce that it will be presenting at the Emerging Growth Metals, Minerals and Energy Conference on May 17, 2023.
  • Mr. Berg will present on the rare earth industry and the Company’s progress on the development of its rare earth processing and separation demonstration plant in Upton, Wyoming.
  • “Rare Element Resources is poised to become a cornerstone for a secure, domestic supply of the critical magnet materials essential to so many hi-tech and green technologies.
  • Rare Element Resources Ltd. is a publicly traded, strategic materials company focused on delivering rare earth products for technology, energy and defense applications by advancing the Bear Lodge Critical Rare Earth Project in northeast Wyoming.

Nutcracker Therapeutics appoints Cynthia Collins, biopharma veteran and former Editas Medicine CEO, to board of directors

Retrieved on: 
Tuesday, May 9, 2023

Nutcracker Therapeutics, Inc. , a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the appointment of Cynthia Collins to the company’s board of directors.

Key Points: 
  • Nutcracker Therapeutics, Inc. , a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the appointment of Cynthia Collins to the company’s board of directors.
  • Collins joins Nutcracker Therapeutics with more than four decades of experience working in the pharmaceutical and biotech industry.
  • Additionally, she is a board member of Poseida Therapeutics (PSTX), Certara (CERT), DermTech (DMTK), Draper Laboratories and Triumvira Immunologics.
  • “We are delighted to welcome Cindy to the board,” says Igor Khandros, Ph.D., CEO of Nutcracker Therapeutics.